Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Amgen Inc AMGN

Healthcare Biotechnology
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AMGN)

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND

PR Newswire December 10, 2024

BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

PR Newswire December 7, 2024

AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA

PR Newswire December 5, 2024

AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE

PR Newswire December 2, 2024

AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE

PR Newswire November 29, 2024

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY

PR Newswire November 26, 2024

AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM

PR Newswire November 26, 2024

AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT

PR Newswire November 20, 2024

AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024

PR Newswire November 14, 2024
View More News ››

Opinion & Analysis (NDAQ:AMGN)

Morning Market Outlook for May 6, 2024

TheUpTrend May 6, 2024

Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

Gail Dutton October 15, 2015

Biotech Bears Spark Good Vibes For These ETFs

Benzinga.com  October 6, 2015

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015

The Other Bearish Biotech ETF Is Looking Groovy, Too

Benzinga.com  August 21, 2015

Even With Recent Declines, Investors Still Love Biotech ETFs

Benzinga.com  July 30, 2015
View More Opinion ››

Bullboard Posts (NDAQ:AMGN)

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE L

JUST IN: $AMGN AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2...
whytestocks - November 26, 2024

Trading Amgen (AMGN)

<< View Post To Watch Video >>
theuptrend - May 5, 2024

Amgen Stock Adds Good Weight After CEO's Update On Experimen

NEWS: $AMGN Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate...
whytestocks - May 3, 2024

RE:RE:IVERMICTIN KILLS COVID 19 !

Does it kill monkeypox?
Joe455 - May 29, 2022

RE:IVERMICTIN KILLS COVID 19 !

Dr. Richard Bartlett on Budesonide, the Silver Bullet ... https://www.thethinkingconservative.com/dr-richard...
zeropointenergy - October 9, 2021

IVERMICTIN KILLS COVID 19 !

 NICE China Reports Zero New Locally Acquired Covid-19 Cases for Fourth Day in a Row  
zeropointenergy - October 9, 2021
View more Bullboard ››

Taranis Resources Inc.

Taranis Resources Inc.

Taranis Resources Inc. is a Canadian mineral exploration company. The Company is principally engaged in the acquisition ...
View More »